329
Views
27
CrossRef citations to date
0
Altmetric
Reviews

Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities

&
Pages 533-544 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

João Cardoso, António Jorge Ferreira, Miguel Guimarães, Ana Sofia Oliveira, Paula Simão & Maria Sucena. (2021) Treatable Traits in COPD – A Proposed Approach. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3167-3182.
Read now
Joanna Miłkowska-Dymanowska, Adam J Białas, Joanna Makowska, Aleksandra Wardzynska, Paweł Górski & Wojciech J Piotrowski. (2017) Geroprotectors as a therapeutic strategy for COPD – where are we now?. Clinical Interventions in Aging 12, pages 1811-1817.
Read now
Junghyun Kim, Jung-Kyu Lee, Eun Young Heo, Hee Soon Chung & Deog Kyeom Kim. (2016) The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2159-2166.
Read now
Ian D Pavord, Paul W Jones, Pierre-Régis Burgel & Klaus F Rabe. (2016) Exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 11:sup1, pages 21-30.
Read now

Articles from other publishers (23)

Lina Sun & Yahong Chen. (2023) Interpretation of the key issues of expert consensus on immunomodulatory therapies for chronic obstructive pulmonary disease. Journal of Translational Internal Medicine 10:4, pages 277-280.
Crossref
Stanislav Kotlyarov. (2022) High-Density Lipoproteins: A Role in Inflammation in COPD. International Journal of Molecular Sciences 23:15, pages 8128.
Crossref
Pujarini Dash, Soumya R. Mohapatra & Sanghamitra Pati. (2022) Metabolomics of Multimorbidity: Could It Be the Quo Vadis?. Frontiers in Molecular Biosciences 9.
Crossref
Stanislav Kotlyarov & Anna Kotlyarova. (2021) Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 22:14, pages 7634.
Crossref
Robert P. Young & Raewyn J. Scott. (2021) Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?. European Respiratory Journal 58:1, pages 2100342.
Crossref
H. Burke & T.M.A. Wilkinson. (2021) Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care. European Respiratory Review 30:160, pages 210041.
Crossref
Velin Stratev, Valentina Dimitrova & Diana Petkova. (2019) COPD and Comorbidities: Relating Mechanisms and Treatment. Current Respiratory Medicine Reviews 15:2, pages 90-101.
Crossref
Aisling Walsh, Lucy Perrem, Ali S Khashan, Michael T Henry & Muireann Ni Chroinin. (2019) Statins versus placebo for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:7.
Crossref
Raymond U. Osarogiagbon, Giulia Veronesi, Wentao Fang, Simon Ekman, Kenichi Suda, Joachim G. Aerts & Jessica Donington. (2019) Early-Stage NSCLC: Advances in Thoracic Oncology 2018. Journal of Thoracic Oncology 14:6, pages 968-978.
Crossref
Jun-Jun Yeh, Shih-Huei Syue, Cheng-Li Lin, Chung Y. Hsu, Zonyin Shae & Chia-Hung Kao. (2019) Effects of statins on anxiety and depression in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Journal of Affective Disorders 253, pages 277-284.
Crossref
Raewyn J Hopkins & Robert P Young. (2023) Mevalonate Signaling, COPD and Cancer: The Statins and Beyond. Journal of Investigative Medicine 67:4, pages 711-714.
Crossref
Joanna Kaluza, Holly Harris, Alice Wallin, Anders Linden & Alicja Wolk. (2018) Dietary Fiber Intake and Risk of Chronic Obstructive Pulmonary Disease. Epidemiology 29:2, pages 254-260.
Crossref
Wen Zhang, Yi Zhang, Chuan-Wei Li, Paul Jones, Chen Wang & Ye Fan. (2017) Effect of Statins on COPD. Chest 152:6, pages 1159-1168.
Crossref
Paolo Giorgini, Paolo Di Giosia, Livia Ferri & Claudio Ferri. (2017) Cardiovascular events in patients with chronic obstructive bronchopulmonary disease. Journal of Cardiovascular Medicine 18, pages e23-e29.
Crossref
J. Ferreira, M. Drummond, N. Pires, G. Reis, C. Alves & C. Robalo-Cordeiro. (2016) Optimal treatment sequence in COPD: Can a consensus be found?. Revista Portuguesa de Pneumologia (English Edition) 22:1, pages 39-49.
Crossref
Aisling Walsh, Lucy M Perrem, Mohamed Elshafi, Ali S Khashan, Michael Henry & Muireann Ni Chroinin. (2015) Statins versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews.
Crossref
Jérôme Lane, Stephan F. van Eeden, Ma’en Obeidat, Don D. Sin, Scott J. Tebbutt, Wim Timens, Dirkje S. Postma, Michel Laviolette, Peter D. Paré & Yohan Bossé. (2015) Impact of Statins on Gene Expression in Human Lung Tissues. PLOS ONE 10:11, pages e0142037.
Crossref
Peter J. Barnes. (2015) Mechanisms of development of multimorbidity in the elderly. European Respiratory Journal 45:3, pages 790-806.
Crossref
A. Vukic Dugac, A. Ruzic, M. Samarzija, S. Badovinac, T. Kehler & M. Jakopovic. (2015) Persistent endothelial dysfunction turns the frequent exacerbator COPD from respiratory disorder into a progressive pulmonary and systemic vascular disease. Medical Hypotheses 84:2, pages 155-158.
Crossref
Nobuyuki Horita, Naoki Miyazawa, Ryota Kojima, Miyo Inoue, Yoshiaki Ishigatsubo, Atsuhisa Ueda & Takeshi Kaneko. (2014) Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respiratory Research 15:1.
Crossref
Robert P. Young & Raewyn J. Hopkins. (2014) Primary and Secondary Prevention of Chronic Obstructive Pulmonary Disease: Where to Next?. American Journal of Respiratory and Critical Care Medicine 190:7, pages 839-840.
Crossref
Robert P Young, Raewyn J Hopkins & Alvar Agusti. (2014) Statins as adjunct therapy in COPD: how do we cope after STATCOPE?. Thorax 69:10, pages 891-894.
Crossref
Robert P. Young & Raewyn J. Hopkins. (2014) High Dietary Fiber Lowers Systemic Inflammation: Potential Utility in COPD and Lung Cancer. The American Journal of Medicine 127:8, pages e13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.